AR070357A1 - Producto para cuidado oral y metodos de uso y manufactura del mismo - Google Patents
Producto para cuidado oral y metodos de uso y manufactura del mismoInfo
- Publication number
- AR070357A1 AR070357A1 ARP090100429A ARP090100429A AR070357A1 AR 070357 A1 AR070357 A1 AR 070357A1 AR P090100429 A ARP090100429 A AR P090100429A AR P090100429 A ARP090100429 A AR P090100429A AR 070357 A1 AR070357 A1 AR 070357A1
- Authority
- AR
- Argentina
- Prior art keywords
- calcium
- oral care
- salt
- composition
- manufacture
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- 150000003839 salts Chemical group 0.000 abstract 3
- 229940024606 amino acid Drugs 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 239000004227 calcium gluconate Substances 0.000 abstract 2
- 229960004494 calcium gluconate Drugs 0.000 abstract 2
- 235000013927 calcium gluconate Nutrition 0.000 abstract 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 abstract 2
- 159000000007 calcium salts Chemical class 0.000 abstract 2
- RWYRUDPAALLKPX-UHFFFAOYSA-N 2,2-difluoro-n-methylethanamine;hydrochloride Chemical compound Cl.CNCC(F)F RWYRUDPAALLKPX-UHFFFAOYSA-N 0.000 abstract 1
- 239000004475 Arginine Substances 0.000 abstract 1
- OPSXJNAGCGVGOG-DKWTVANSSA-L Calcium L-aspartate Chemical compound [Ca+2].[O-]C(=O)[C@@H](N)CC([O-])=O OPSXJNAGCGVGOG-DKWTVANSSA-L 0.000 abstract 1
- CBOCVOKPQGJKKJ-UHFFFAOYSA-L Calcium formate Chemical compound [Ca+2].[O-]C=O.[O-]C=O CBOCVOKPQGJKKJ-UHFFFAOYSA-L 0.000 abstract 1
- 239000001749 Calcium fumarate Substances 0.000 abstract 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 abstract 1
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 229940034055 calcium aspartate Drugs 0.000 abstract 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 abstract 1
- 239000001354 calcium citrate Substances 0.000 abstract 1
- 229960004256 calcium citrate Drugs 0.000 abstract 1
- 235000019296 calcium fumarate Nutrition 0.000 abstract 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 abstract 1
- 229940095618 calcium glycerophosphate Drugs 0.000 abstract 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 abstract 1
- 239000001527 calcium lactate Substances 0.000 abstract 1
- 229960002401 calcium lactate Drugs 0.000 abstract 1
- 235000011086 calcium lactate Nutrition 0.000 abstract 1
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 abstract 1
- 239000001362 calcium malate Substances 0.000 abstract 1
- 229940016114 calcium malate Drugs 0.000 abstract 1
- 235000011038 calcium malates Nutrition 0.000 abstract 1
- 235000010331 calcium propionate Nutrition 0.000 abstract 1
- 239000004330 calcium propionate Substances 0.000 abstract 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 abstract 1
- 150000001735 carboxylic acids Chemical class 0.000 abstract 1
- 235000013337 tricalcium citrate Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Reivindicacion 1: Una composicion para cuidado oral caracterizada porque comprende: a) una cantidad efectiva de un aminoácido básico, en forma libre o en forma de sal; b) una cantidad efectiva de una sal de calcio soluble seleccionada de glicerofosfato de calcio y sales de ácidos carboxílicos solubles. Reivindicacion 2: Una composicion para cuidado oral de acuerdo con la reivindicacion 1, caracterizada porque el aminoácido básico es arginina o una sal del mismo. Reivindicacion 3: Una composicion para cuidado oral de acuerdo con la reivindicacion 1 o 2 caracterizada porque la sal de calcio se selecciona de citrato de calcio, malato de calcio, lactato de calcio, formato de calcio, fumarato de calcio, gluconato de calcio, lactato gluconato de calcio, aspartato de calcio y propionato de calcio; y mezclas de los mismos.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2743108P | 2008-02-08 | 2008-02-08 | |
| US2742008P | 2008-02-08 | 2008-02-08 | |
| US2743508P | 2008-02-08 | 2008-02-08 | |
| US2743208P | 2008-02-08 | 2008-02-08 | |
| US2744208P | 2008-02-09 | 2008-02-09 | |
| US2744408P | 2008-02-09 | 2008-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR070357A1 true AR070357A1 (es) | 2010-03-31 |
Family
ID=40952692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090100429A AR070357A1 (es) | 2008-02-08 | 2009-02-06 | Producto para cuidado oral y metodos de uso y manufactura del mismo |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20110014136A1 (es) |
| EP (1) | EP2217202A4 (es) |
| JP (1) | JP2011515332A (es) |
| CN (1) | CN101938982B (es) |
| AR (1) | AR070357A1 (es) |
| AU (1) | AU2009212319B2 (es) |
| BR (1) | BRPI0906453A2 (es) |
| CA (1) | CA2707085C (es) |
| MX (1) | MX2010005006A (es) |
| RU (1) | RU2013124842A (es) |
| TW (1) | TWI374753B (es) |
| WO (1) | WO2009100263A2 (es) |
| ZA (1) | ZA201003687B (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI438953B (zh) | 2008-01-30 | 2014-05-21 | Osram Opto Semiconductors Gmbh | 電子組件之製造方法及電子組件 |
| MY159577A (en) | 2010-11-12 | 2017-01-13 | Colgate Palmolive Co | Oral care product and methods of use and manufacture thereof |
| DE102011003882A1 (de) * | 2011-02-09 | 2012-08-09 | Sb Limotive Company Ltd. | Zusammensetzung zum Löschen und/oder Hemmen von Fluor- und/oder Phosphor-haltigen Bränden |
| US9149528B2 (en) | 2011-10-13 | 2015-10-06 | Premier Dental Products Company | Topical vitamin D oral supplement compositions |
| CN107648070A (zh) | 2011-12-15 | 2018-02-02 | 高露洁-棕榄公司 | 水性口腔护理组合物 |
| US9877930B2 (en) * | 2012-10-12 | 2018-01-30 | Premier Dental Products Company | Topical ubiquinol oral supplement compositions with amorphous calcium phosphate |
| US9724542B2 (en) | 2012-10-12 | 2017-08-08 | Premier Dental Products Company | Remineralizing and desensitizing compositions, treatments and methods of manufacture |
| WO2014088535A1 (en) | 2012-12-03 | 2014-06-12 | Colgate-Palmolive Company | Compositions and methods for treating dental caries |
| MX354873B (es) * | 2012-12-06 | 2018-03-23 | Colgate Palmolive Co | Sistemas de tensoactivo para composiciones que contienen zinc. |
| JP2015096473A (ja) * | 2013-11-15 | 2015-05-21 | 第一三共ヘルスケア株式会社 | 唾液分泌促進剤及びそれを含有する口腔用組成物 |
| EP3076920B1 (en) | 2013-12-03 | 2019-04-17 | Colgate-Palmolive Company | Oral care compositions |
| JP6751027B2 (ja) * | 2014-07-11 | 2020-09-02 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 非晶質リン酸カルシウムを供給する口腔ケア処方システム |
| MX365972B (es) | 2014-12-23 | 2019-06-21 | Colgate Palmolive Co | Composiciones para el cuidado bucal. |
| JP6795316B2 (ja) * | 2015-03-18 | 2020-12-02 | 第一三共ヘルスケア株式会社 | Ｌ−アスパラギン酸またはその塩、及びニコチンアミドを含有する口腔ケア用組成物 |
| JP2018104302A (ja) * | 2016-12-22 | 2018-07-05 | 花王株式会社 | 歯磨剤用顆粒の製造方法 |
| CN110325172A (zh) * | 2017-03-16 | 2019-10-11 | 江崎格力高株式会社 | 能够促进牙齿的再矿化的口腔用组合物 |
| CN112533579A (zh) | 2018-07-16 | 2021-03-19 | 3M创新有限公司 | 通过减少口腔生物膜中的乳酸释放来治疗龋齿的含氨基酸口腔护理组合物 |
| WO2020205342A1 (en) * | 2019-03-29 | 2020-10-08 | Colgate-Palmolive Company | Oral care product |
| US11260009B2 (en) * | 2019-03-29 | 2022-03-01 | Colgate-Palmolive Company | Oral care product and methods of use and manufacture thereof |
| EP4072686A1 (en) | 2019-12-12 | 2022-10-19 | 3M Innovative Properties Company | Oral care composition with n-acetyl amino acid components for treating caries |
| EP3848017A1 (en) | 2020-01-08 | 2021-07-14 | 3M Innovative Properties Company | Oral care composition containing indole components for treating caries |
| WO2021167845A1 (en) | 2020-02-18 | 2021-08-26 | Sunstar Americas, Inc. | Oral care composition |
| CN114504646B (zh) * | 2022-02-18 | 2022-11-04 | 深圳南粤药业有限公司 | 一种含粘蛋白的人工唾液组合物及其制备方法与应用 |
| CN115400039A (zh) * | 2022-10-17 | 2022-11-29 | 涌智(上海)生物科技有限公司 | 一种口腔酸碱平衡制剂及其应用 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3538230A (en) | 1966-12-05 | 1970-11-03 | Lever Brothers Ltd | Oral compositions containing silica xerogels as cleaning and polishing agents |
| US3678154A (en) | 1968-07-01 | 1972-07-18 | Procter & Gamble | Oral compositions for calculus retardation |
| US3535421A (en) | 1968-07-11 | 1970-10-20 | Procter & Gamble | Oral compositions for calculus retardation |
| US4154815A (en) | 1970-04-01 | 1979-05-15 | Lever Brothers Company | Zinc and enzyme toothpowder dentifrice |
| US3696191A (en) | 1970-11-10 | 1972-10-03 | Monsanto Co | Dental creams containing enzymes |
| US4058595A (en) | 1971-10-13 | 1977-11-15 | Colgate-Palmolive Company | Stabilized toothpastes containing an enzyme |
| US3959458A (en) | 1973-02-09 | 1976-05-25 | The Procter & Gamble Company | Oral compositions for calculus retardation |
| US3937807A (en) | 1973-03-06 | 1976-02-10 | The Procter & Gamble Company | Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies |
| US3862307A (en) | 1973-04-09 | 1975-01-21 | Procter & Gamble | Dentifrices containing a cationic therapeutic agent and improved silica abrasive |
| US3991177A (en) | 1973-11-27 | 1976-11-09 | Colgate-Palmolive Company | Oral compositions containing dextranase |
| US4051234A (en) | 1975-06-06 | 1977-09-27 | The Procter & Gamble Company | Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies |
| US4355022A (en) | 1981-07-01 | 1982-10-19 | Interon, Inc. | Method of dental treatment |
| US4885155A (en) | 1982-06-22 | 1989-12-05 | The Procter & Gamble Company | Anticalculus compositions using pyrophosphate salt |
| US5000939A (en) | 1984-06-12 | 1991-03-19 | Colgate-Palmolive Company | Dentifrice containing stabilized enzyme |
| CH671879A5 (es) | 1987-02-26 | 1989-10-13 | Nestle Sa | |
| US4866161A (en) | 1987-08-24 | 1989-09-12 | University Of South Alabama | Inhibition of tartar deposition by polyanionic/hydrophobic peptides and derivatives thereof which have a clustered block copolymer structure |
| US5004597A (en) | 1987-09-14 | 1991-04-02 | The Procter & Gamble Company | Oral compositions comprising stannous flouride and stannous gluconate |
| US4842847A (en) | 1987-12-21 | 1989-06-27 | The B. F. Goodrich Company | Dental calculus inhibiting compositions |
| US5438076A (en) * | 1988-05-03 | 1995-08-01 | Perio Products, Ltd. | Liquid polymer composition, and method of use |
| EP0551675A1 (en) * | 1991-12-31 | 1993-07-21 | Unilever N.V. | Oral hygiene compositions containing antiplaque agents |
| US5505933A (en) * | 1994-06-27 | 1996-04-09 | Colgate Palmolive Company | Desensitizing anti-tartar dentifrice |
| DE69523440T2 (de) * | 1995-04-05 | 2002-05-29 | Unilever N.V., Rotterdam | Mundpflegemittel |
| DE69618786T2 (de) * | 1995-07-10 | 2002-11-07 | Unilever N.V., Rotterdam | Wärmeerzeugende zahnpasta |
| US5762911A (en) * | 1996-03-05 | 1998-06-09 | The Research Foundation Of State University Of New York | Anti-caries oral compositions |
| US6436370B1 (en) * | 1999-06-23 | 2002-08-20 | The Research Foundation Of State University Of New York | Dental anti-hypersensitivity composition and method |
| GB2354441A (en) * | 1999-08-06 | 2001-03-28 | Mccormack Ltd | Composition for treating dentine hypersensitivity |
| JP3977553B2 (ja) * | 1999-09-02 | 2007-09-19 | 花王株式会社 | 液状口腔用組成物 |
| GB9922871D0 (en) * | 1999-09-28 | 1999-12-01 | Mccormack Limited | A novel method for the temporary attenuation of dentine hypersensitivity |
| US6372198B1 (en) * | 2000-09-14 | 2002-04-16 | Joseph M. Abbate | Dentifrice for the mineralization and remineralization of teeth |
| US20060099239A1 (en) * | 2002-04-15 | 2006-05-11 | Coleman Henry D | Dietary supplement for promoting removal of heavy metals from the body |
| KR100513117B1 (ko) * | 2002-07-31 | 2005-09-07 | 구본길 | 애완동물의 구강 및 치아 보호용 놀이기구 |
| US6946151B2 (en) * | 2002-11-12 | 2005-09-20 | Ayurvedic-Life International, Llc | Therapeutic compositions |
| KR20060066732A (ko) * | 2003-08-19 | 2006-06-16 | 베링거 인겔하임 인터내셔날 게엠베하 | 어린이 또는 청소년을 위한 종합비타민 시럽 |
| JP4496070B2 (ja) * | 2003-12-26 | 2010-07-07 | 花王株式会社 | 口腔用組成物 |
| CN102358746A (zh) * | 2005-12-16 | 2012-02-22 | 戴维·坎纳尔 | 表面活性钙磷酸盐 |
| US20070184111A1 (en) * | 2006-02-03 | 2007-08-09 | Pharmavite Llc | Hybrid tablet |
-
2009
- 2009-02-06 AR ARP090100429A patent/AR070357A1/es unknown
- 2009-02-06 CA CA2707085A patent/CA2707085C/en active Active
- 2009-02-06 CN CN200980104885.7A patent/CN101938982B/zh active Active
- 2009-02-06 EP EP20090708692 patent/EP2217202A4/en not_active Ceased
- 2009-02-06 WO PCT/US2009/033289 patent/WO2009100263A2/en active Application Filing
- 2009-02-06 AU AU2009212319A patent/AU2009212319B2/en active Active
- 2009-02-06 MX MX2010005006A patent/MX2010005006A/es active IP Right Grant
- 2009-02-06 US US12/866,622 patent/US20110014136A1/en not_active Abandoned
- 2009-02-06 BR BRPI0906453-2A patent/BRPI0906453A2/pt not_active IP Right Cessation
- 2009-02-06 TW TW098103765A patent/TWI374753B/zh not_active IP Right Cessation
- 2009-02-06 JP JP2010546014A patent/JP2011515332A/ja active Pending
-
2010
- 2010-05-24 ZA ZA2010/03687A patent/ZA201003687B/en unknown
-
2013
- 2013-05-28 RU RU2013124842/15A patent/RU2013124842A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2013124842A (ru) | 2014-12-10 |
| EP2217202A4 (en) | 2014-01-08 |
| EP2217202A2 (en) | 2010-08-18 |
| CN101938982A (zh) | 2011-01-05 |
| JP2011515332A (ja) | 2011-05-19 |
| CN101938982B (zh) | 2014-06-04 |
| AU2009212319A1 (en) | 2009-08-13 |
| WO2009100263A3 (en) | 2009-10-22 |
| CA2707085C (en) | 2013-11-26 |
| ZA201003687B (en) | 2015-06-24 |
| WO2009100263A2 (en) | 2009-08-13 |
| BRPI0906453A2 (pt) | 2015-07-14 |
| US20110014136A1 (en) | 2011-01-20 |
| TWI374753B (en) | 2012-10-21 |
| TW200946133A (en) | 2009-11-16 |
| AU2009212319B2 (en) | 2012-11-15 |
| CA2707085A1 (en) | 2009-08-13 |
| MX2010005006A (es) | 2010-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR070357A1 (es) | Producto para cuidado oral y metodos de uso y manufactura del mismo | |
| CO6300929A2 (es) | Composicion oral que contiene amino acidos y sal soluble de calcio | |
| CO6300927A2 (es) | Sales de arginina y un cation, productos de cuidado oral y personal que los contienen y metodos para preparar dichas sales y productos | |
| AR094070A1 (es) | Haluro de zinc aminoacidos / trimetilglicina | |
| MY149730A (en) | Oral care product and methods of use and manufacture thereof | |
| SV2010003770A (es) | Composicion y proceso- 356 | |
| ECSP088490A (es) | Forma farmacéutica oral que contiene como principios activos un inhibidor de la bomba de protones junto con ácido acetilsalicílico | |
| TW200716138A (en) | Stable active compound complex of salts of O-acetylsalicylic acid with basic amino acids and glycine | |
| ATE412410T1 (de) | Verwendung der salze, anlagerungs- und komplexverbindungen der guanidinoessigsäure | |
| CR20140053A (es) | Formulaciones de ácido desoxicólico y sales del mismo | |
| CY1120852T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει ιβουπροφαινη, τραμαδολη και ενα βασικο αμινοξυ, μεθοδος παρασκευης αυτης και χρηση της ιδιας | |
| RU2009101326A (ru) | Препарат для наружного применения на кожу, содержащий тритерпеновую кислоту | |
| AR076433A1 (es) | Sales inhibidoras de cdk | |
| MX358716B (es) | Composiciones estables para el cuidado bucal que comprenden un aminoácido básico , una sal de estroncio y una fuente de ion fluoruro y usos de las mismas. | |
| AR070593A1 (es) | Composiciones efervescentes | |
| AR044802A1 (es) | Sales farmaceuticamente aceptables, de derivados de acidos carboxilicos | |
| EA201791191A1 (ru) | Водные фармацевтические композиции для местного применения в ротовой полости, содержащие флурбипрофен и декспантенол | |
| PE20081402A1 (es) | Sales de timo depresores farmaceuticamente aceptables y procesos para su manufactura | |
| AR093717A1 (es) | Composiciones y metodos para el tratamiento de la caries dental | |
| ATE366734T1 (de) | Benzochinolizin-2-carbonsäureargininsalz- tetrahydrat | |
| PE20091209A1 (es) | Sales de propionato de 3-(2,2,2-trimetilhidrazinio) | |
| TH123649A (th) | ผลิตภัณฑ์ดูแลช่องปาก และวิธีการใช้ และวิธีการผลิตผลิตภัณฑ์นี้ | |
| ES2427429B1 (es) | Composición cosmética para el tratamiento de cabello | |
| AR101572A2 (es) | Sales de arginina y composiciones | |
| MY147881A (en) | N[s(4-aryl-triazol-3-yl)?-mercaptoacetyl]-p-amino benzoic acids as hiv reverse transcriptase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |